A medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine.


Updates from The Motley Fool

Latest updates on BIOLASE from Fool.com.


Stock Performance

BIOL vs. S&P 500 | 2 Year Performance
View Interactive BIOL Charts
Sponsored by

Key Data Points

Primary metrics and data points about BIOLASE.
Current Price: $1.13
Prev Close: $1.16
Open: $1.17
Bid: $0.99
Ask: $1.27
Day's Range: $1.01 - $1.27
52wk Range: $0.60 - $1.72
Volume: 108,677
Avg Vol 47,708
Market Cap: $65.80M
P/E (ttm): -3.62
EPS (ttm): -$0.32
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about BIOLASE.
CAPS Rating 1 out of 5
 
71 Outperform
27 Underperform
CAPS All Stars
 
6 Outperform
11 Underperform

How do you think BIOLASE will perform against the market?



You pick for BIOLASE is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Harold Flynn, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for BIOLASE.

A medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Healthcare IT